1. Home
  2. VRNA vs HIMS Comparison

VRNA vs HIMS Comparison

Compare VRNA & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • HIMS
  • Stock Information
  • Founded
  • VRNA 2005
  • HIMS 2017
  • Country
  • VRNA United Kingdom
  • HIMS United States
  • Employees
  • VRNA N/A
  • HIMS N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • HIMS Medical/Nursing Services
  • Sector
  • VRNA Health Care
  • HIMS Health Care
  • Exchange
  • VRNA Nasdaq
  • HIMS Nasdaq
  • Market Cap
  • VRNA 8.3B
  • HIMS 9.4B
  • IPO Year
  • VRNA 2017
  • HIMS N/A
  • Fundamental
  • Price
  • VRNA $104.83
  • HIMS $48.66
  • Analyst Decision
  • VRNA Buy
  • HIMS Hold
  • Analyst Count
  • VRNA 11
  • HIMS 11
  • Target Price
  • VRNA $112.40
  • HIMS $39.36
  • AVG Volume (30 Days)
  • VRNA 5.5M
  • HIMS 46.3M
  • Earning Date
  • VRNA 08-07-2025
  • HIMS 08-04-2025
  • Dividend Yield
  • VRNA N/A
  • HIMS N/A
  • EPS Growth
  • VRNA N/A
  • HIMS N/A
  • EPS
  • VRNA N/A
  • HIMS 0.68
  • Revenue
  • VRNA $118,535,000.00
  • HIMS $1,784,353,000.00
  • Revenue This Year
  • VRNA $891.79
  • HIMS $62.41
  • Revenue Next Year
  • VRNA $78.94
  • HIMS $19.85
  • P/E Ratio
  • VRNA N/A
  • HIMS $70.24
  • Revenue Growth
  • VRNA N/A
  • HIMS 85.99
  • 52 Week Low
  • VRNA $17.96
  • HIMS $13.47
  • 52 Week High
  • VRNA $104.99
  • HIMS $72.98
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 70.87
  • HIMS 46.96
  • Support Level
  • VRNA $86.63
  • HIMS $45.04
  • Resistance Level
  • VRNA $104.99
  • HIMS $52.33
  • Average True Range (ATR)
  • VRNA 2.73
  • HIMS 3.55
  • MACD
  • VRNA 0.50
  • HIMS -0.07
  • Stochastic Oscillator
  • VRNA 99.24
  • HIMS 68.82

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About HIMS Hims & Hers Health Inc.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Share on Social Networks: